Last reviewed · How we verify
SK-MS10
At a glance
| Generic name | SK-MS10 |
|---|---|
| Sponsor | SK Chemicals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SK-MS10 CI brief — competitive landscape report
- SK-MS10 updates RSS · CI watch RSS
- SK Chemicals Co., Ltd. portfolio CI